Answers are grounded in this paper and cite their sources.
During the last years, proteomics has facilitated biomarker discovery by coupling high-throughput techniques with novel nanosensors. In the present review, we focus on the study of label-based and label-free detection systems, as well as nanotechnology approaches, indicating their advantages and applications in biomarker discovery. In addition, several disease biomarkers are shown in order to display the clinical importance of the improvement of sensitivity and selectivity by using nanoproteomics approaches as novel sensors.
No takes yet. Share an insight, caveat, or question.
Dasilva et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: